Rainer Bischoff, Centre of Pharmacy, University of Groningen, The Netherlands,
"Activity-dependent profiling of metalloproteases: photoaffinity - labelling and affinity-solid-phase extraction"
Dolores Cahill, University of Dublin, Ireland
“Recent applications of protein microarrays in protein and antibody interaction screening for proteome-wide applications”
Juan J. Calvete, Laboratorio de Proteinómica Estructural Instituto de Biomedicina de Valencia, C.S.I.C, Spain
”Venomic and antivenomic tools for exploring snake venom proteomes and improving the management of snakebite envenoming, a neglected pathology”
Mike Dunn, University College Dublin, Dublin, Ireland
"Proteomics of heart failure: the cardiac hydrophobic sub-proteome"
Tomasz Dylag, European Commission, Brussels, Belgium
"Opportunities for proteomics in the 7th Framework Programme of the European Union"
Thomas E. Fehniger, AstraZeneca R&D Lund, Lund, Sweden
"What We Need from Proteomics in the Clinic"
Michael Gillette, Harvard Medical School & Dana-Farber Cancer Institute
"An Integrated Discovery to Verification Pipeline for Clinical Proteomics"
Lukas A. Huber, Innsbruck Medical University, Austria
“Organelle- and Phoshoproteomics of MAPK signaling”
Peter Juhasz, BG Medicine, Boston, USA
"A Systems Level Study of Stable and Unstable (Ruptured) Atherosclerotic Plaque"
Michael Karas, Johann Wolfgang Goethe University, Germany,
"New MALDI matrices for Improved Performance in Protein Identification and Characterization"
Tadashi Kondo, Japan
”Cancer proteomics for personalized medicine: Predictive biomarker for better treatment”
Martin Kussmann, Functional Genomics, Nestlé Research Center, Switzerland,
"Nutrigenomics and Personalized Nutrition in Health & Disease - Science and Concept"
Riitta Lahesmaa, Turku Centre for Biotechnology, Finland
"Systems Biology of T Cell Activation and Differentiation"
Angus Lamond, University of Dundee, Scotland
"Mapping protein localisation and dynamics"
Hanno Langen, Molecular Medicine Laboraties, Switzerland
”From Protein Biomarker Discovery to Clinical Validation in Pharmaceutical and Diagnostic Industry”
Matthias Mann, Max-Planck Institute for Biochemistry, Germany,
"Cell signaling studied by quantitative proteomics"
Tony Pawson, Mount Sinai Hospital, Canada
"Proteomic analysis of reciprocal cell signalling"
Markus Stoeckli, Novartis Pharma, Switzerland
"Mass Spectrometric Imaging: A Critical Evaluation"
Michael Sundström, The Novo Nordisk Foundation Center for Protein Research, Denmark,
"High Throughput and Systematic Analysis of Medically Relevant Proteins"
Mathias Uhlén, Royal Institute of Technology (KTH), Sweden,
"Antibody-based profiling as a tool for clinical proteomics"
Roman Zubarev, Laboratory for Biological and Medical Mass Spectrometry, Uppsala University, Sweden,
"Pathway Analysis via Protein Expression Measurements - 'Why's and 'How's"
Torben F. Ørntoft, Aarhus University Hospital, Denmark
"Molecular Medicine, examples from bladder and colon cancer on translation of molecular findings into clinical biomarkers"
